戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  memory B cells as well as the production of fully human antibodies.
2                                            A fully human antibody, 19G9, was generated against mindin
3 b phage display library, we have generated a fully human antibody (A12) that binds to the IGF-IR with
4  effective and safe immunotherapeutic drugs, fully-human antibodies affinity-matured in a healthy hos
5                               Panitumumab, a fully human antibody against the epidermal growth factor
6  antibodies (that are rapidly convertible to fully human antibodies) and have fully functional humora
7 ng a valuable platform for the generation of fully human antibodies as therapeutics.
8 hesis clinically, we developed (89)Zr-5B1, a fully human, antibody-based radiotracer targeting tumor-
9 latory approval of panitumumab (Vectibix), a fully human antibody directed against epidermal growth f
10                                      Being a fully human antibody, E7.6.3 is expected to exhibit mini
11 med by the rapid progression of 10 different fully human antibodies into human clinical trials.
12 onoclonal antibodies, allowing the design of fully human antibodies of any specificity and for divers
13 immunoglobulin G1 Fc region to construct the fully human antibody scFv-FcC21, which recognized tumors
14                              Ipilimumab is a fully human antibody targeting CTLA-4 that received FDA
15                               Panitumumab, a fully human antibody targeting the epidermal growth fact
16                                MEDI-573 is a fully human antibody that neutralizes both IGF-I and IGF
17                   Additionally, Fab A11 is a fully human antibody that specifically inhibits matripta
18 nomics and with methods now in place to make fully human antibodies, the potential of antibodies as v
19 ional engineering methodology for generating fully human antibody therapeutics from murine mAbs produ
20 n enables the mice to generate high affinity fully human antibodies to multiple antigens, including h
21 een used to generate numerous high-affinity, fully human antibodies to targets in multiple disease in
22 14 patients with metastatic melanoma using a fully human antibody to cytotoxic T-lymphocyte antigen-4
23                               Nivolumab is a fully human antibody which is routinely used at first th
24 mor necrosis factor alpha, we have generated fully human antibodies with 59, 46, and 45 substitutions

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。